QA: Melinta Therapeutics INC NEW in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001461993_2015_Melinta_Therapeutics_INC_NEW.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001461993, Melinta Therapeutics INC NEW

  xvar xval
0 AssetsCurrent 104,851,313
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 113,146
3 remainder_Assets 346,228
4 LiabilitiesCurrent 18,085,704
5 LiabilitiesNoncurrent 14,878,114
6 remainder_Liabilities 11,325,946
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,076,767
9 ResearchAndDevelopmentExpense 62,539,108
10 remainder_Expenses 0
11 remainder_Revenues 15,215,934
12 remainder_NetIncome -2,249,329
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 105,310,687
1 Liabilities 44,289,764
2 Expenses 74,615,875
3 Revenues 15,215,934
4 StockholdersEquity 61,020,923
5 NetIncome -61,649,270
6 ComprehensiveNetIncome -61,649,270
7 BaseVar 120,840,794
8 EconomicCapitalRatiobeforeLimitedLiability 0.954
9 EconomicCapitalRatio 2.27

Edgar->Model Mapping

Feature Distribution

Change over Time